CSL Seqirus, a business of CSL (ASX: CSL), announced recent data showing that cell-based influenza vaccines offer greater protection in preventing test-confirmed influenza compared to standard ...

Late in the Middle Ages, Italian stargazers gave a name to the annual contagion that rolled around each year like clockwork.

The immunological arms race between virus and vaccines may change in the future, at least for bird flu viruses. Scientists ...

CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.

Viruses have no metabolism of their own and must therefore infect host cells in order to replicate. Contact between the virus and the cell surface is a crucial first step, which can also prevent ...

After a summer lull in U.S. cases of avian influenza in both poultry and dairy cattle—and no human infections reported in the ...

Experiments suggests H9N2 has adapted to human cells but cases of person-to-person transmission haven’t been reported yet.

December 12, 2011 — Children with sickle cell anemia who receive the trivalent inactivated influenza vaccine are no more likely to be hospitalized for sickle cell crisis than children with sickle cell ...